Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BHVN | Biohaven Ltd. | Chief Executive Officer, Director | $129 M | +$15 M | +13.2% | Apr 22, 2024 |
RVNC | Revance Therapeutics, Inc. | Director | $79 K | May 1, 2024 | ||
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | Oct 3, 2022 | |||
AKLI | Akili, Inc. | Director | Jun 29, 2021 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|